Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = APOE*3Leiden.CETP mice

Search results

  • RSS Feed
(1 - 5 of 5)
The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice
Landlinger, C.; Pouwer, M.G.; Juno, C.; Hoorn, J.W.A. van der; Pieterman, E.J.; Jukema, J.W.; ... ; Galabova, G. 2017
The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice
Article / Letter to editor
open access
innovative pharmaceutical interventions in cardiovascular disease: focusing on the contribution of non-HDL-C/LDL-C-lowering versus HDL-C-raising. A systematic review and meta-analysis of relevant preclinical studies and clinical trials
Kühnast, S.; Fiocco, M.; Hoorn, J.W.A. van der; Princen, H.M.G.; Jukema, J.W. 2015
innovative pharmaceutical interventions in cardiovascular disease: focusing on the contribution of non-HDL-C/LDL-C-lowering versus HDL-C-raising. A systematic review and meta-analysis of relevant preclinical studies and clinical trials
Article / Letter to editor
metadata only
Innovative pharmaceutical interventions in cardiovascular disease: Focusing on the contribution of non-HDL-C/LDL-C-lowering versus HDL-C-raising A systematic review and meta-analysis of relevant preclinical studies and clinical trials
Kuhnast, S.; Fiocco, M.; Hoorn, J.W.A. van der; Princen, H.M.G.; Jukema, J.W. 2015
Innovative pharmaceutical interventions in cardiovascular disease: Focusing on the contribution of non-HDL-C/LDL-C-lowering versus HDL-C-raising A systematic review and meta-analysis of relevant preclinical studies and clinical trials
Article / Letter to editor
metadata only
Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin
Kuhnast, S.; Hoorn, J.W.A. van der; Pieterman, E.J.; Hoek, A.M. van den; Sasiela, W.J.; Gusarova, V.; ... ; Princen, H.M.G. 2014
Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin
Article / Letter to editor
metadata only
Aliskiren inhibits atherosclerosis development and improves plaque stability in APOEM*3Leiden.CETP transgenic mice with or without treatment with atorvastatin
Kuhnast, S.; Hoorn, J.W.A. van der; Hoek, A.M. van den; Havekes, L.M.; Liau, G.; Jukema, J.W.; Princen, H.M.G. 2012
Aliskiren inhibits atherosclerosis development and improves plaque stability in APOEM*3Leiden.CETP transgenic mice with or without treatment with atorvastatin
Article / Letter to editor
metadata only